U.S. Patent and Trademark Office Issues Mylan's Specialty Division, Dey L.P., Three Additional Patents Protecting Perforomist Inhalation Solution

Mylan Inc. today announced that its subsidiary Dey L.P. has been issued several additional U.S. patents protecting the company's Perforomist Inhalation Solution, a chronic obstructive pulmonary disease (COPD) treatment.

The details can be read here.